About
ModernaTX, Inc. holds U.S. biologics license No. 2256 for Spikevax, an mRNA COVID-19 vaccine.
Sources3
- 1Government recordOfficial ModernaTX legal_name evidence
U.S. Food and Drug Administration · Aug 27, 2026 · Supports Organization · description, Organization · legal name
“We have approved your request received June 5, 2026, to supplement your Biologics License Application (BLA) submitted under section 351(a) of the Public Health Service Act for COVID-19 Vaccine, mRNA (SPIKEVAX)”
- 2Government recordOfficial ModernaTX description evidence
U.S. Food and Drug Administration · Jan 31, 2022 · Supports Organization · description
“We are issuing Department of Health and Human Services U.S. License No. 2256 to ModernaTX, Inc., Cambridge, Massachusetts, under the provisions of section 351(a) of the PHS Act controlling the manufacture and sale of biological products. Under this license, you are authorized to manufacture the product COVID-19 Vaccine, mRNA”
- 3Government recordOfficial ModernaTX country evidence
U.S. General Services Administration · Supports Organization · country
“"legal_name": "MODERNATX, INC.", "dba": "", "physical": { "line1": "325 BINNEY ST", "line2": "", "city": "CAMBRIDGE", "region": "MA", "postal": "02142", "country": "USA" },”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.